{"id":355702,"date":"2023-05-26T20:30:38","date_gmt":"2023-05-27T00:30:38","guid":{"rendered":"https:\/\/www.sgtreport.com\/?p=355702"},"modified":"2023-05-26T05:40:57","modified_gmt":"2023-05-26T09:40:57","slug":"neuralink-receives-fda-go-ahead-for-first-human-trials","status":"publish","type":"post","link":"https:\/\/www.sgtreport.com\/2023\/05\/neuralink-receives-fda-go-ahead-for-first-human-trials\/","title":{"rendered":"Neuralink Receives FDA Go-Ahead for First Human Trials"},"content":{"rendered":"

from Sputnik News<\/a>:<\/em><\/p>\n

\"\"<\/p>\n

\n
Neuralink’s ambitious goal is to create a seamless connection between human brains and computers, enabling individuals to communicate and interact with machines in unprecedented ways.<\/div>\n<\/div>\n
\n
\n
In a groundbreaking development for the field of neurotechnology, Neuralink, the brain-machine interface company founded by Elon Musk, has received the approval from the US Food and Drug Administration to conduct its first human trials.<\/div>\n<\/div>\n<\/div>\n

TRUTH LIVES on at\u00a0https:\/\/sgtreport.tv\/<\/a><\/p>\n

\n
Neuralink is aiming to develop high-bandwidth interfaces that can be implanted into the human brain, allowing for bidirectional communication between the mind and external devices.<\/div>\n<\/div>\n
\n
The FDA’s approval of Neuralink’s human trials signifies a significant vote of confidence in the company’s innovative technology and its potential to revolutionize the lives of individuals with neurological conditions and disabilities.<\/div>\n<\/div>\n
\n
\n
\n
\n
\"Message<\/div>\n<\/div>\n
Message from the official Neuralink account on receipt of approval from the FDA.<\/div>\n